<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3754">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 19, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01927367</url>
  </required_header>
  <id_info>
    <org_study_id>IMPACT-AF-2013</org_study_id>
    <nct_id>NCT01927367</nct_id>
  </id_info>
  <brief_title>Integrated Management Program Advancing Community Treatment of Atrial Fibrillation</brief_title>
  <acronym>IMPACT-AF</acronym>
  <official_title>Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jafna L Cox</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Population Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Joseph's Healthcare Hamilton</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Nova Scotia Health Authority</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Research Question: Among community-based patients with AF, does providing an integrated&#xD;
      Clinical Decision Support System (CDSS) to providers and patients improve process of care and&#xD;
      clinical outcomes, and decrease the healthcare costs and resource utilization over 12 months,&#xD;
      as compared to usual care?&#xD;
&#xD;
      Intervention: A web-based clinical decision support system, computerizing the Canadian AF&#xD;
      clinical guidelines, to support primary care providers and patients in optimizing and&#xD;
      standardizing AF care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Atrial fibrillation (AF) is the most common abnormality of cardiac rhythm. It is also a&#xD;
      disease of aging, affecting 3% of adults aged &gt; 45 years and 12% of those aged &gt; 75.&#xD;
      Individually, AF's rapid and irregular heart beat is most frequently perceived as undesirable&#xD;
      palpitations, but more threatening impacts are heart failure, catastrophic stroke and&#xD;
      premature death. AF also markedly impairs quality of life.&#xD;
&#xD;
      Although patients with AF are at increased risk of stroke, death and hospitalization, many&#xD;
      patients are not benefiting from evidence-informed, best-care strategies. Gaps have been&#xD;
      documented in the knowledge, skills and competencies of primary care clinicians concerning&#xD;
      the management of AF in Canada. For example, a large proportion of AF patients at moderate to&#xD;
      high risk for stroke do not receive guideline recommended thromboprophylaxis; and of those&#xD;
      that do, many are not optimally controlled. One Canadian study also found that in patient&#xD;
      with known AF and a prior stroke, who were then admitted with a second stroke, 15% were not&#xD;
      on any anticoagulation and only 18% were on warfarin and within the therapeutic range.&#xD;
      Opportunities certainly exist to enhance the uptake of the Canadian AF Clinical Practice&#xD;
      Guideline recommendations and best-care approaches in the primary care setting.&#xD;
&#xD;
      Patients need to be the focus of care services and be actively engaged and empowered to&#xD;
      manage their care, with the support of health care providers. We believe that health system&#xD;
      efficiency, care quality and patient safety can be enhanced through the use of innovative,&#xD;
      integrated, interactive, pro-active and personalized point-of- care solutions targeting both&#xD;
      providers and patients. This is the premise for the IMPACT-AF study.&#xD;
&#xD;
      Primary care providers and their patients are anticipated to benefit from enhanced use of&#xD;
      health information technology regarding the management of patients with AF. A clinical&#xD;
      guideline-based decision support system (CDSS) will be developed and tested in primary care&#xD;
      settings across Nova Scotia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2013</start_date>
  <completion_date type="Actual">November 2018</completion_date>
  <primary_completion_date type="Actual">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Cardiovascular Hospitalization and AF-related Emergency Department Visits</measure>
    <time_frame>12 months</time_frame>
    <description>Any unplanned hospitalization (admission with an overnight stay in hospital) due to one of the following causes: acute coronary syndrome, pre-syncope /syncope, transient ischemic attack/ stroke, atrial fibrillation, flutter, pulmonary embolism /deep vein thrombosis /systemic embolism, worsening congestive heart failure including pulmonary edema or dyspnea of cardiac origin. AF-related ED visit was predefined as: any presentation with palpitations, rapid heart rate, presyncope or syncope, shortness of breath, transient chest discomfort, or hemodynamic instability resolving with cardioversion or rate-control, not resulting in hospitalization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With AF-related Emergency Department Visits</measure>
    <time_frame>12 months</time_frame>
    <description>Individual element of primary outcome.&#xD;
AF-related emergency department visits.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Process of Care</measure>
    <time_frame>12 months</time_frame>
    <description>Timely access to specialist consultation&#xD;
Timely access to echocardiograms&#xD;
Timely access to catheter ablations for AF and atrial flutter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Related Quality of Life</measure>
    <time_frame>12 months</time_frame>
    <description>- Health Related Quality of Life measured using an accepted health questionnaire (EQ-5D-5L).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs</measure>
    <time_frame>12 months</time_frame>
    <description>The costs associated with the development, implementation, and maintenance of CDSS.&#xD;
The costs associated with managing and treating patients with AF.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost Effectiveness</measure>
    <time_frame>12 months</time_frame>
    <description>- Incremental cost effectiveness ratio between the interventional arm and the control arm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participations With CV Hospitalizations</measure>
    <time_frame>12 months</time_frame>
    <description>Individual element of primary outcome.&#xD;
AF-related emergency department visits.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of Participants With Major Bleeding</measure>
    <time_frame>12 months</time_frame>
    <description>Major bleeding, as listed above, is to be defined as fatal bleeding and/or symptomatic bleeding in a critical area or organ, such as intracranial, intraspinal, intraocular, retroperitoneal, intra-articular or pericardial, or intramuscular with compartment syndrome and /or overt bleeding causing a fall in hemoglobin level of 20 g/L or more, or leading to transfusion of two or more units of whole blood or red cells.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1145</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Clinical Decision Support System for AF</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Providers randomized to use the Clinical Decision Support System (CDSS, a web-based tool).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual Care - providers are not eligible to access / use the CDSS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinical Decision Support System for AF</intervention_name>
    <description>A web-based clinical decision support system, computerizing the Canadian AF clinical guidelines and best-practice approaches, to support primary care providers and patients in optimizing and standardizing AF care.</description>
    <arm_group_label>Clinical Decision Support System for AF</arm_group_label>
    <other_name>CDSS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;/= 18 years (no max age limit)&#xD;
&#xD;
          -  Confirmed atrial fibrillation.&#xD;
&#xD;
          -  Able to provide informed consent in English.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients unable to provide informed consent.&#xD;
&#xD;
          -  Patients who are not expected to be alive at the end of the 12 month follow up.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jafna L Cox, MD, FRCPC, FACC</last_name>
    <role>Principal Investigator</role>
    <affiliation>CDHA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Syed Sibte Raza Abidi, MSc, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Dalhousie University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Capital District Health Authority</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 3A7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Healthcare Hamilton</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>https://www.sciencedirect.com/science/article/pii/S0002870318301170</url>
    <description>IMPACT-AF Rationale and methods</description>
  </link>
  <link>
    <url>https://www.sciencedirect.com/science/article/pii/S0002870320300855</url>
    <description>IMPACT-AF: A cluster randomized trial of a computerized clinical decision support tool</description>
  </link>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>August 20, 2013</study_first_submitted>
  <study_first_submitted_qc>August 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2013</study_first_posted>
  <results_first_submitted>April 16, 2020</results_first_submitted>
  <results_first_submitted_qc>August 27, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 16, 2020</results_first_posted>
  <last_update_submitted>February 12, 2021</last_update_submitted>
  <last_update_submitted_qc>February 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nova Scotia Health Authority</investigator_affiliation>
    <investigator_full_name>Jafna L Cox</investigator_full_name>
    <investigator_title>Staff Cardiologist</investigator_title>
  </responsible_party>
  <keyword>Clinical Decision Support System</keyword>
  <keyword>Primary Health Care</keyword>
  <keyword>Clinical Practice Guidelines</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data (IPD) is not available due to ethics regulations.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 9, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/67/NCT01927367/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 26, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/67/NCT01927367/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>One participant did not meet inclusion criteria and was excluded from the analysis.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Clinical Decision Support System for AF</title>
          <description>Providers randomized to access use of the Clinical Decision Support System (CDSS, a web-based tool).&#xD;
Clinical Decision Support System for AF: A web-based clinical decision support system, computerizing the Canadian AF clinical guidelines and best-practice approaches, to support primary care providers and patients in optimizing and standardizing AF care.</description>
        </group>
        <group group_id="P2">
          <title>Usual Care</title>
          <description>Usual Care - providers are not eligible to access / use the CDSS.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="597"/>
                <participants group_id="P2" count="548"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="590"/>
                <participants group_id="P2" count="543"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>No baseline data</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Clinical Decision Support System for AF</title>
          <description>Providers randomized to access use of the Clinical Decision Support System (CDSS, a web-based tool).&#xD;
Clinical Decision Support System for AF: A web-based clinical decision support system, computerizing the Canadian AF clinical guidelines and best-practice approaches, to support primary care providers and patients in optimizing and standardizing AF care.</description>
        </group>
        <group group_id="B2">
          <title>Usual Care</title>
          <description>Usual Care - providers are not eligible to access / use the CDSS.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="590"/>
            <count group_id="B2" value="543"/>
            <count group_id="B3" value="1133"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72.5" spread="10.1"/>
                    <measurement group_id="B2" value="72.1" spread="9.9"/>
                    <measurement group_id="B3" value="72.3" spread="10.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="239"/>
                    <measurement group_id="B2" value="193"/>
                    <measurement group_id="B3" value="432"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="351"/>
                    <measurement group_id="B2" value="350"/>
                    <measurement group_id="B3" value="701"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Ethnicity</title>
              <category_list>
                <category>
                  <title>Caucasian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="329"/>
                    <measurement group_id="B2" value="308"/>
                    <measurement group_id="B3" value="637"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="216"/>
                    <measurement group_id="B2" value="200"/>
                    <measurement group_id="B3" value="416"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <title>Rural Care Nova Scotia</title>
                  <measurement_list>
                    <measurement group_id="B1" value="315"/>
                    <measurement group_id="B2" value="298"/>
                    <measurement group_id="B3" value="613"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Urban Care Nova Scotia</title>
                  <measurement_list>
                    <measurement group_id="B1" value="275"/>
                    <measurement group_id="B2" value="245"/>
                    <measurement group_id="B3" value="520"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Cardiovascular Hospitalization and AF-related Emergency Department Visits</title>
        <description>Any unplanned hospitalization (admission with an overnight stay in hospital) due to one of the following causes: acute coronary syndrome, pre-syncope /syncope, transient ischemic attack/ stroke, atrial fibrillation, flutter, pulmonary embolism /deep vein thrombosis /systemic embolism, worsening congestive heart failure including pulmonary edema or dyspnea of cardiac origin. AF-related ED visit was predefined as: any presentation with palpitations, rapid heart rate, presyncope or syncope, shortness of breath, transient chest discomfort, or hemodynamic instability resolving with cardioversion or rate-control, not resulting in hospitalization.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clinical Decision Support System for AF</title>
            <description>Providers randomized to access use of the Clinical Decision Support System (CDSS, a web-based tool).&#xD;
Clinical Decision Support System for AF: A web-based clinical decision support system, computerizing the Canadian AF clinical guidelines and best-practice approaches, to support primary care providers and patients in optimizing and standardizing AF care.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care - providers are not eligible to access / use the CDSS.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Cardiovascular Hospitalization and AF-related Emergency Department Visits</title>
          <description>Any unplanned hospitalization (admission with an overnight stay in hospital) due to one of the following causes: acute coronary syndrome, pre-syncope /syncope, transient ischemic attack/ stroke, atrial fibrillation, flutter, pulmonary embolism /deep vein thrombosis /systemic embolism, worsening congestive heart failure including pulmonary edema or dyspnea of cardiac origin. AF-related ED visit was predefined as: any presentation with palpitations, rapid heart rate, presyncope or syncope, shortness of breath, transient chest discomfort, or hemodynamic instability resolving with cardioversion or rate-control, not resulting in hospitalization.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="590"/>
                <count group_id="O2" value="543"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118"/>
                    <measurement group_id="O2" value="130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With AF-related Emergency Department Visits</title>
        <description>Individual element of primary outcome.&#xD;
AF-related emergency department visits.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clinical Decision Support System for AF</title>
            <description>Providers randomized to access use of the Clinical Decision Support System (CDSS, a web-based tool).&#xD;
Clinical Decision Support System for AF: A web-based clinical decision support system, computerizing the Canadian AF clinical guidelines and best-practice approaches, to support primary care providers and patients in optimizing and standardizing AF care.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care - providers are not eligible to access / use the CDSS.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With AF-related Emergency Department Visits</title>
          <description>Individual element of primary outcome.&#xD;
AF-related emergency department visits.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="590"/>
                <count group_id="O2" value="543"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78"/>
                    <measurement group_id="O2" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Process of Care</title>
        <description>Timely access to specialist consultation&#xD;
Timely access to echocardiograms&#xD;
Timely access to catheter ablations for AF and atrial flutter</description>
        <time_frame>12 months</time_frame>
        <population>Data were not available/collected from primary care provider charts that would permit analysis of the time between dates of referral and dates of access for the process of care outcomes.</population>
        <group_list>
          <group group_id="O1">
            <title>Clinical Decision Support System for AF</title>
            <description>Providers randomized to access use of the Clinical Decision Support System (CDSS, a web-based tool).&#xD;
Clinical Decision Support System for AF: A web-based clinical decision support system, computerizing the Canadian AF clinical guidelines and best-practice approaches, to support primary care providers and patients in optimizing and standardizing AF care.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care - providers are not eligible to access / use the CDSS.</description>
          </group>
        </group_list>
        <measure>
          <title>Process of Care</title>
          <description>Timely access to specialist consultation&#xD;
Timely access to echocardiograms&#xD;
Timely access to catheter ablations for AF and atrial flutter</description>
          <population>Data were not available/collected from primary care provider charts that would permit analysis of the time between dates of referral and dates of access for the process of care outcomes.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Health Related Quality of Life</title>
        <description>- Health Related Quality of Life measured using an accepted health questionnaire (EQ-5D-5L).</description>
        <time_frame>12 months</time_frame>
        <posting_date>06/2021</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Costs</title>
        <description>The costs associated with the development, implementation, and maintenance of CDSS.&#xD;
The costs associated with managing and treating patients with AF.</description>
        <time_frame>12 months</time_frame>
        <posting_date>09/2021</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cost Effectiveness</title>
        <description>- Incremental cost effectiveness ratio between the interventional arm and the control arm</description>
        <time_frame>12 months</time_frame>
        <posting_date>09/2021</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participations With CV Hospitalizations</title>
        <description>Individual element of primary outcome.&#xD;
AF-related emergency department visits.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clinical Decision Support System for AF</title>
            <description>Providers randomized to access use of the Clinical Decision Support System (CDSS, a web-based tool).&#xD;
Clinical Decision Support System for AF: A web-based clinical decision support system, computerizing the Canadian AF clinical guidelines and best-practice approaches, to support primary care providers and patients in optimizing and standardizing AF care.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care - providers are not eligible to access / use the CDSS.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participations With CV Hospitalizations</title>
          <description>Individual element of primary outcome.&#xD;
AF-related emergency department visits.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="590"/>
                <count group_id="O2" value="543"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants With Major Bleeding</title>
        <description>Major bleeding, as listed above, is to be defined as fatal bleeding and/or symptomatic bleeding in a critical area or organ, such as intracranial, intraspinal, intraocular, retroperitoneal, intra-articular or pericardial, or intramuscular with compartment syndrome and /or overt bleeding causing a fall in hemoglobin level of 20 g/L or more, or leading to transfusion of two or more units of whole blood or red cells.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clinical Decision Support System for AF</title>
            <description>Providers randomized to access use of the Clinical Decision Support System (CDSS, a web-based tool).&#xD;
Clinical Decision Support System for AF: A web-based clinical decision support system, computerizing the Canadian AF clinical guidelines and best-practice approaches, to support primary care providers and patients in optimizing and standardizing AF care.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual Care - providers are not eligible to access / use the CDSS.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Major Bleeding</title>
          <description>Major bleeding, as listed above, is to be defined as fatal bleeding and/or symptomatic bleeding in a critical area or organ, such as intracranial, intraspinal, intraocular, retroperitoneal, intra-articular or pericardial, or intramuscular with compartment syndrome and /or overt bleeding causing a fall in hemoglobin level of 20 g/L or more, or leading to transfusion of two or more units of whole blood or red cells.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="590"/>
                <count group_id="O2" value="543"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected over 12 months for each participant's active study phase.</time_frame>
      <desc>Safety outcomes were monitored and reported at 12 months, including Major bleeding per ISTH criteria as well as All bleeding.</desc>
      <group_list>
        <group group_id="E1">
          <title>Clinical Decision Support System for AF</title>
          <description>Providers randomized to access use of the Clinical Decision Support System (CDSS, a web-based tool).&#xD;
Clinical Decision Support System for AF: A web-based clinical decision support system, computerizing the Canadian AF clinical guidelines and best-practice approaches, to support primary care providers and patients in optimizing and standardizing AF care.</description>
        </group>
        <group group_id="E2">
          <title>Usual Care</title>
          <description>Usual Care - providers are not eligible to access / use the CDSS.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="590"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="543"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="590"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="543"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Major bleeding per ISTH criteria</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="590"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="543"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="590"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="543"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Limitations can be found in the main outcomes paper, which is open access: https://www.sciencedirect.com/science/article/pii/S0002870320300855 The methods paper is also open access: https://www.sciencedirect.com/science/article/pii/S0002870318301170</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Jafna L Cox</name_or_title>
      <organization>QEII Health Sciences Centre, Halifax, Nova Scotia</organization>
      <phone>(902) 473-7811</phone>
      <email>jafna.cox@dal.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

